Panbela Therapeutics (PBLA) News Today → The Gold Grab of the Century (From Colonial Metals) (Ad) Free PBLA Stock Alerts $0.44 +0.03 (+7.32%) (As of 04/25/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlinePanbela Therapeutics Announces Interim Data Analysis for ASPIRE Trial Pushed to Q1 2025globenewswire.com - April 22 at 8:00 AMPanbela Applies to List on CBOEmarketwatch.com - April 18 at 6:11 PMPanbela Announces Poster Presentation at American Association for Cancer Research:globenewswire.com - April 18 at 8:00 AMPanbela Therapeutics, Inc.: Panbela Announces Transfer to OTCQB Marketfinanznachrichten.de - April 17 at 9:49 AMPanbela Announces Transfer to OTCQB Marketfinance.yahoo.com - April 16 at 7:24 PMRecap: Panbela Therapeutics Q4 Earningsbenzinga.com - March 28 at 7:34 PMPanbela Therapeutics, Inc. (PBLA) Q4 2023 Earnings Call Transcriptseekingalpha.com - March 28 at 2:34 PMPanbela Therapeutics, Inc. (NASDAQ:PBLA) Q4 2023 Earnings Call Transcriptmsn.com - March 27 at 3:10 PMPanbela Therapeutics, Inc.: Panbela Provides Business Update and Reports Q4 and FY 2024 Financial Resultsfinanznachrichten.de - March 27 at 10:09 AMPanbela Provides Business Update and Reports Q4 and FY 2024 Financial Resultsglobenewswire.com - March 26 at 4:10 PMEarnings Preview: Panbela Therapeuticsbenzinga.com - March 26 at 1:12 AMPBLA Panbela Therapeutics, Inc.seekingalpha.com - March 22 at 11:01 PMPanbela to Host Fourth Quarter and Year End 2023 Earnings Conference Call on March 26, 2024globenewswire.com - March 12 at 4:15 PMTop 4 Health Care Stocks That Are Preparing To Pump This Monthmsn.com - February 23 at 11:40 PMTop 4 Health Care Stocks That Are Preparing To Pump This Month - ProSomnus (NASDAQ:OSA), GRI Bio (NASDAQ:GRI)benzinga.com - February 23 at 7:50 AMPanbela Regains Compliance with Nasdaq Listing Standards for Bid Price and Publicly Held Shares Requirementsfinance.yahoo.com - February 15 at 11:37 AMPanbela Regains Compliance with Nasdaq Listing Standards for Bid Price and Publicly Held Shares Requirementsglobenewswire.com - February 15 at 8:00 AMPanbela Announces Closing of Approximately $9.0 Million Public Offeringfinance.yahoo.com - February 1 at 9:59 AMPanbela Therapeutics Inc (PBLA)investing.com - January 31 at 8:53 AMPanbela Therapeutics, Inc.: Acceptance of Ivospemin (SBP-101) Abstract for Poster Presentation at American Association for Cancer Research (AACR)finanznachrichten.de - January 30 at 3:23 PMWhat's Going On With Panbela Therapeutics Stock Today?benzinga.com - January 30 at 10:23 AMAcceptance of Ivospemin (SBP-101) Abstract for Poster Presentation at American Association for Cancer Research (AACR)finance.yahoo.com - January 30 at 10:23 AMPanbela Therapeutics, Processa Pharmaceuticals among healthcare moversmsn.com - January 29 at 1:25 PMPanbela Therapeutics Prices $9 Mln Share Offeringmarkets.businessinsider.com - January 29 at 1:25 PMWhy Is Panbela Therapeutics (PBLA) Stock Down 63% Today?investorplace.com - January 29 at 10:03 AMPanbela Therapeutics Shares Slide Premarket After Public Offeringmarketwatch.com - January 29 at 8:24 AMPanbela Therapeutics drops on $9M public offeringmsn.com - January 29 at 8:24 AMPanbela Announces Pricing of Approximately $9.0 Million Public Offeringfinance.yahoo.com - January 29 at 8:24 AMWhat's Going On With Panbela Therapeutics Stock?msn.com - January 26 at 8:06 PMmarketbeat.com - January 26 at 9:42 AMPanbela Exceeds 50% Enrollment for Aspire Trial in Pancreatic Cancer, Exceeding Anticipated Timelines with Accelerated Momentumfinance.yahoo.com - January 25 at 8:36 AMmarketbeat.com - January 23 at 9:39 AMPanbela Therapeutics Touch 52-Week Low on Planned Public Offeringmarketwatch.com - January 22 at 5:53 PMmarketbeat.com - January 18 at 1:07 PMPanbela Announces Publication of Clinical Data Titled: Phase 1 study of high-dose DFMO, celecoxib, cyclophosphamide and topotecan for patients with relapsed neuroblastoma: A New Approaches to Neuroblastoma Therapy Trialfinance.yahoo.com - January 18 at 8:25 AMmarketbeat.com - January 18 at 6:05 AMPanbela Announces 1-for-20 Reverse Stock Split Effective January 18, 2024finance.yahoo.com - January 16 at 8:32 AMPanbela Therapeutics' stock skyrockets after positive FDA news on child cancer treatmentmorningstar.com - December 21 at 6:25 PMPanbela Therapeutics Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $2.0 Million Gross Proceeds Priced At-the-Marketfinance.yahoo.com - December 21 at 1:24 PMPanbela Therapeutics (PBLA) Stock Is Down 25%: What's Going On?msn.com - December 20 at 7:21 PMWhat In The World Is Going On With Panbela Therapeutics (PBLA) Stock?msn.com - December 19 at 1:02 PMPanbela Therapeutics at Roth MKM, here's whyrealmoney.thestreet.com - December 18 at 3:18 PMWhat's Going On With Panbela Therapeutics (PBLA) Stock?msn.com - December 18 at 3:18 PMPanbela Therapeutics, Inc.: Panbela Therapeutics Announces US WorldMeds NDA Approval for Eflornithine (DFMO) in Pediatric Neuroblastomafinanznachrichten.de - December 18 at 10:17 AMPanbela Therapeutics Announces US WorldMeds NDA Approval for Eflornithine (DFMO) in Pediatric Neuroblastomafinance.yahoo.com - December 18 at 10:17 AMBuy Rating Affirmed for Panbela Therapeutics Following FDA Approval and Positive Trial Progressmarkets.businessinsider.com - December 15 at 11:43 PMPanbela Announces Publication of Abstract Titled: Evaluation of Myeloma Cell Lines Viability Following Administration of SBP-101 and DFMO Polyamine Inhibitorsfinance.yahoo.com - December 4 at 12:21 PMPositive Outlook for Panbela Therapeutics Backed by Buy Rating and Clinical Progressmarkets.businessinsider.com - November 30 at 8:26 AMPanbela Announces 2nd Independent Safety Review of the ASPIRE Registration Clinical Trial: Recommended Continuation with no Trial Modificationfinance.yahoo.com - November 29 at 10:37 AMPanbela Therapeutics, Inc. (NASDAQ:PBLA) Q3 2023 Earnings Call Transcriptinsidermonkey.com - November 12 at 2:56 PM Get Panbela Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for PBLA and its competitors with MarketBeat's FREE daily newsletter. Email Address The Best AI Stock to Own in the World Today is Trading for Just $25 (Ad)“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet. See how you can invest alongside him PBLA Media Mentions By Week PBLA Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PBLA News Sentiment▼0.000.41▲Average Medical News Sentiment PBLA News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PBLA Articles This Week▼12▲PBLA Articles Average Week Get Panbela Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for PBLA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Dermata Therapeutics News Today Comera Life Sciences News Today InMed Pharmaceuticals News Today Qualigen Therapeutics News Today Galmed Pharmaceuticals News Today Lucy Scientific Discovery News Today GRI Bio News Today Bio-Path News Today Clearmind Medicine News Today Histogen News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PBLA) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchThe AI stock to buy right nowStockEarningsThe only accurate crypto trading system I know …Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Panbela Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
